Navigation Links
Intellikine Appoints William Rohn to its Board of Directors
Date:2/23/2010

LA JOLLA, Calif., Feb. 23 /PRNewswire/ -- Intellikine, Inc., a leader in the development of drugs against the PI3K/mTOR pathway, today announced that William R. Rohn has joined the company's board of directors.

Mr. Rohn has over 30 years of management experience in the biotechnology and pharmaceutical industry, including more than 10 years in executive management positions at IDEC Pharmaceuticals and Biogen Idec, where he served as Chief Operating Officer until his retirement in 2005.  He joined IDEC in 1993 as Senior Vice President, Commercial and Corporate Development, was appointed Senior Vice President, Commercial Operations and was promoted to Chief Operating Officer in 1998. In 2002, he became President, responsible for Sales, Marketing, Business Development, Manufacturing, Quality, Medical Affairs and CMC Regulatory Affairs.  He was responsible for building IDEC's commercial infrastructure to support the launch of Rituxan, the first monoclonal antibody approved in the U.S. for the treatment of cancer.  Mr. Rohn serves on the boards of directors of Elan Corporation, plc, Cerus Corporation, and Cebix, Inc.

"We are delighted to welcome Bill Rohn to Intellikine's board of directors," said Troy Wilson, Ph.D., J.D., President and CEO of Intellikine.  "His strategic insights and experience in growing biotechnology companies, including his experience transitioning IDEC from a development stage company to a very successful commercial enterprise, will be invaluable to Intellikine as we seek to advance our growing pipeline of drugs against the PI3K/mTOR pathway."

"Intellikine has rapidly built one of the best pipelines against the PI3K/mTOR pathway," said William Rohn.  "I am excited about the opportunity to work with the management team and board to build the company and, in particular, to forge industry-leading partnerships to develop and commercialize the company's products for the treatment of cancer, inflammation and other serious diseases."

About Intellikine

Intellikine is a private, clinical-stage company focused on the discovery and development of innovative small molecule drugs targeting the PI3K/mTOR pathway.  Intellikine recently announced the start of a Phase I trial for INK128, a selective TORC1/2 inhibitor for oncology and is advancing INK1197, a PI3K-delta/gamma dual-selective inhibitor for the treatment of inflammatory and respiratory diseases.  Other programs include PI3K-delta/gamma dual-selective inhibitors for oncology, PI3K-alpha/beta selective inhibitors for oncology, as well as other isoform-selective inhibitors. Intellikine has raised $41 million from an outstanding group of life science investors including Abingworth, Sofinnova Ventures, CMEA Capital, Novartis Venture Funds, U.S. Venture Partners, Biogen Idec and FinTech Global Capital.  In addition, Intellikine has a commitment, subject to fulfillment of certain conditions, for another $22.5 million in equity financing from its current investors.  For more information, please visit the company's website at www.intellikine.com.

SOURCE Intellikine, Inc.

Back to top

RELATED LINKS
http://www.intellikine.com

'/>"/>

SOURCE Intellikine, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aton Pharma Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations
2. TechTeam Global Appoints Life Sciences Services Director
3. ADVENTRX Appoints Icahn Representative to Board of Directors
4. MS&L Appoints Patricia Archambault as Vice President, Healthcare in Montreal
5. Encorium Re-Appoints Dr. Kai Lindevall as Chief Executive Officer and Appoints Current Director, Shahab Fatheazam, Chairman of the Board
6. Avantium Appoints Gunnar Staaf as CEO Pharma
7. In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors
8. Millstone Medical Outsourcing Appoints New Leadership of Memphis Facility
9. Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer
10. Jazz Pharmaceuticals Appoints Kathryn Falberg as Chief Financial Officer
11. Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 Around the corners of world, cancer ... habitable land present over earth. Cancer has become one ... a life time this is because of the increasing ... Given the steady increase in global cancer incidence with ... healthcare costs of treatment, there is increasing interest in ...
(Date:12/2/2016)... -- The iShares Nasdaq Biotechnology Exchange-Traded Fund has ... early in November. Less political risk has boosted the ... an uptick in M&A activities. Today, Stock-Callers.com takes a ... have fared at the last close: Celldex Therapeutics Inc. ... FOLD ), Navidea Biopharmaceuticals Inc. (NYSE MKT: ...
(Date:11/30/2016)... , Nov. 30, 2016  Millennium Dental Technologies, Inc. announced ... in the Superior Court of the State of ... alleging violation of the California,s Uniform ... unfair and fraudulent business practices which are untrue and misleading, ... This is the second time in three years ...
Breaking Medicine Technology:
(Date:12/2/2016)... Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... lien basis to help personal injury victims find high quality medical care. When the ... Los Angeles area. Fast forward to present day and the now ten-page directory features ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, a trusted name in ... trial program for all of the company’s desktop riser products. A simple application ... experience. , FlexiSpot’s unique desktop risers use an advanced dual gas spring hovering ...
(Date:12/2/2016)... ... December 02, 2016 , ... U.S. Surgeon General, Dr. ... Mediaplanet, Dr. Murthy explains how he was inspired to practice medicine at an early ... medicine is about more than making diagnoses and prescribing medicine,” he states. “It is ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... California, will be included in the 2016 “Guide to America’s Top Plastic Surgeons” ... on the amalgamation of their education, experience, and professional associations. , One ...
(Date:12/2/2016)... Delaware (PRWEB) , ... December 02, 2016 , ... ... released a new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps ... sample entry through labeling, storing, shipping and disposal. The new version is a ...
Breaking Medicine News(10 mins):